Ameritas Investment Partners’s Filana Therapeutics FLNA Stock Holding History

Ameritas Investment Partners’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,951	Closed	-$5.93K	–	3324
2025 Q1	$5.93K	Hold	3,951	–	–	﹤0.01%	2940
2024 Q4	$9.32K	Hold	3,951	–	–	﹤0.01%	2921
2024 Q3	$116K	Hold	3,951	–	–	﹤0.01%	1684
2024 Q2	$48.8K	Hold	3,951	–	–	﹤0.01%	2152
2024 Q1	$80.2K	Hold	3,951	–	–	﹤0.01%	1875
2023 Q4	$88.9K	Hold	3,951	–	–	﹤0.01%	1816
2023 Q3	$65.7K	Buy	3,951 +951	+32%	+$18.8K	﹤0.01%	1931
2023 Q2	$73.6K	Hold	3,000	–	–	﹤0.01%	1795
2023 Q1	$72.4K	Hold	3,000	–	–	﹤0.01%	1745
2022 Q4	$109K	Hold	3,000	–	–	﹤0.01%	1527
2022 Q3	$125K	Hold	3,000	–	–	0.01%	1342
2022 Q2	$84K	Hold	3,000	–	–	﹤0.01%	1640
2022 Q1	$111K	Hold	3,000	–	–	﹤0.01%	1576
2021 Q4	$131K	Hold	3,000	–	–	﹤0.01%	1526
2021 Q3	$186K	Hold	3,000	–	–	0.01%	1252
2021 Q2	$256K	Buy	3,000 +238	+9%	+$12.7K	0.01%	1066
2021 Q1	$124K	Buy	2,762 +715	+35%	+$28.1K	﹤0.01%	1534
2020 Q4	$14K	Hold	2,047	–	–	﹤0.01%	2652
2020 Q3	$24K	Hold	2,047	–	–	﹤0.01%	2289
2020 Q2	$6K	Buy	+2,047	New	+$9.28K	﹤0.01%	2922

Other funds holding FLNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Ameritas Investment Partners's FLNA Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 3,951 shares — an estimated $5.93K sold.

Ameritas Investment Partners first reported a position in FLNA in Q2 2020 and held it in 20 quarters. The position peaked at $256K in Q2 2021. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

Ameritas Investment Partners reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 3,951 Filana Therapeutics shares in Q2 2025, an estimated $5.93K.
Ameritas Investment Partners first reported a position in Filana Therapeutics in Q2 2020 and held it in 20 quarters.
Ameritas Investment Partners's Filana Therapeutics position peaked at $256K in Q2 2021.
97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.